Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

MP BIOMEDICALS LLC

MP Biomedicals manufactures and sells a comprehensive line of in-vitro diagnostics solutions to hospitals and clinica... read more Featured Products: More products

Download Mobile App





MP Biomedicals Exhibits Diagnostics Kits and Sample Prep Solutions at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 24 Jun 2021
MP Biomedicals (Irvine, CA, USA) exhibited its range of diagnostics kits and sample prep solutions at MEDLAB Middle East 2021.

At this year’s edition of MEDLAB Middle East 2021, the company presented the FastPrep family of homogenizers - a comprehensive laboratory solution that optimizes the lysis, grinding, or homogenization process from virtually any sample type. More...
Mechanical lysis disrupts cells and tissues for the isolation of DNA, RNA, proteins, metabolites, and other small molecules, and eliminates the need for chemicals, enzymes, and detergents, which can inhibit some downstream processes. FastPrep instruments, Lysing Matrix tubes, and kits work together to deliver rapid, consistent, and efficient lysis and homogenization, resulting in high yields of purified nucleic acid or protein. A benchtop instrument utilizing bead-beating technology, the FastPrep provides complete and quantitative lysis of difficult and routine samples and is suitable in all applications that require grinding, lysing, or homogenization.

MP Biomedicals also showcased the AutoBlot System 36, an intelligent Western Blot processor that enables automated washing and incubation of up to 36 assay strips per run at pre-selected temperature. The AutoBlot System 36 helps to satisfy Immunoblot needs by minimizing human error, increasing productivity, and delivering accurate and consistent results.

Among its range of diagnostics kits, the company featured the Rapid SARS-CoV-2 Antigen Test Card which is a rapid, chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present on human nasal, nasopharyngeal or oropharyngeal swab specimens. Other products exhibited at the event included the Helico Blot 2.1 qualitative Western Blot Assay for the detection of IgG antibodies to H. pylori in human serum or plasma; ELISA and RIA new born screening panel for earlier diagnosis to confirm if a newborn requires essential medical intervention; HIV Blot 2.2 immunoblot for the in-vitro detection of antibodies to HIV in human serum or plasma samples; HTLV Blot 2.4 for the in-vitro detection of antibodies to HTLV-I and HTLV-II in human serum or plasma; HCV Blot 3.0 qualitative line blot immunoassay for the detection of antibodies to HCV; and the fully automated and integrated MPure-12 nucleic acid purification system to purify nucleic acids of the highest yield and purity for downstream applications.

Related Links:
MP Biomedicals


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.